WIPO logo
모바일 | Deutsch | English | Español | Français | 日本語 | Português | Русский | 中文 | العربية |
PATENTSCOPE

국제 및 국내 특허문헌 검색
World Intellectual Property Organization
검색
 
열람
 
번역
 
옵션
 
뉴스
 
로그인
 
도움말
 
maximize
기계 번역
1. (WO2014121077) METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs)
국제사무국에 기록된 최신 서지정보   

공개번호:    WO/2014/121077    국제출원번호:    PCT/US2014/014160
공개일: 07.08.2014 국제출원일: 31.01.2014
IPC:
C12N 5/079 (2010.01), C12N 5/074 (2010.01)
출원인: THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES [US/US]; National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325, MSC 7660 Bethesda, MD 20852-7660 (US)
발명자: BHARTI, Kapil; (US).
DAVIS, Janine; (US).
MAMINISHKIS, Arvydas; (US).
FERRER-ALEGRE, Marc; (US).
MILLER, Sheldon, S.; (US)
대리인: SIEGEL, Susan, Alpert; Klarquist Sparkman, LLP One World Trade Center, Suite 1600 121 SW Salmon Street Portland, OR 97204 (US)
우선권 정보:
61/759,988 01.02.2013 US
발명의 명칭: (EN) METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs)
(FR) PROCÉDÉ DE GÉNÉRATION DE CELLULES ÉPITHÉLIALES PIGMENTAIRES RÉTINIENNES (EPR) À PARTIR DE CELLULES SOUCHES PLURIPOTENTES INDUITES (CSPI)
요약서: front page image
(EN)High efficiency methods for producing retinal pigment epithelial cells from induced pluripotent stem cells (iPSCs) are disclosed herein. The iPSCs are produced from somatic cells, including retinal pigment epithelial (RPE) cells, such as fetal RPE stem cells. In some embodiments, the iPSC include a tyrosinase promoter operably linked to a marker. Methods are disclosed for using the RPE cells, such as for treatment. Methods for screening for agents that affect RPE differentiation are also disclosed.
(FR)La présente invention concerne des procédés très efficaces de production de cellules épithéliales pigmentaires rétiniennes à partir de cellules souches pluripotentes induites (CSPi). Les CSPi sont produites à partir de cellules somatiques et, notamment, de cellules épithéliales pigmentaires rétiniennes (EPR), telles que les cellules souches EPR fœtales. Selon certains modes de réalisation, les CSPi comprennent un promoteur de la tyrosinase en liaison fonctionnelle avec un marqueur. L'invention concerne également des procédés d'utilisation desdites cellules EPR, par exemple à des fins de traitement. L'invention concerne, en outre, des procédés de criblage permettant de rechercher des agents ayant une incidence sur la différentiation des cellules EPR.
지정국: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
공개언어: English (EN)
출원언어: English (EN)